Cantor Fitzgerald restated their overweight rating on shares of Celldex Therapeutics (NASDAQ:CLDX – Free Report) in a ...

As we enter the new year, cryptocurrency has been enjoying a thriving environment, with every angle turning out in its favor.

Cantor Fitzgerald lowered their FY2024 EPS estimates for shares of CVS Health in a report issued on Tuesday, December 31st.

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target of $29.00. The ...

Poseida Therapeutics Inc (PSTX) stock saw a decline, ending the day at $9.4 which represents a decrease of $-0.20 or -2.08% from the prior close of $9.6. The stock opened at $9.54 and touched a low of ...

Trump and his associates have embraced crypto enthusiastically. His nominee for commerce secretary, Howard Lutnick, controls ...

Cantor Fitzgerald raised the firm’s price target on Axsome Therapeutics (AXSM) to $124 from $121 and keeps an Overweight rating on the shares ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Mustang Bio Inc (MBIO) stock saw a modest uptick, ending the day at $0.21 which represents a slight increase of $0.03 or 16.67% from the prior close of $0.18. The stock opened at $0.18 and touched a ...

We began 2024 with the Delaware Supreme Court’s decision in Cantor Fitzgerald, L.P. v. Ainslie. We end the year with further clarity around the ...